Hence, the HRH1 knockout or inhibition of HRH1 on macrophages with antihistamines reshaped the transcriptomic landscape of immune cells and blocked immune resistance when combined with anti-PD-1 treatment in mammary tumor and colon cancer mice models. Here, HRH1 is linked to breast cancer.